Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent or Refractory T/NK-cell Malignancies

Clinical trial condition

Recurrent or Refractory T/NK-cell Malignancies

Explore clinical trials studying Recurrent or Refractory T/NK-cell Malignancies. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Recurrent or Refractory T/NK-cell Malignancies trial results

Completed

Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies

NCT00823355

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Investigational Site Nagoya, Aichi-ken, Japan

Investigational Site Nagasaki, Japan

Investigational Site Cyuo, Tokyo, Japan

View Trial Details